4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001144204-15-068109
President, CEO & Director acquired 150,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
OAKES FRANK R. · President, CEO & Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-11-24 | Option exercise : show line 1 in the form | −150,000 | $2.50 | $375,000 | 193,965 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-11-24 | Option exercise : show line 2 in the form Call Option (Obligation to Sell) | −150,000 | 0 | D |
Loading xslF345X03/v425620_4.xml…